MDX receives FDA clearance for PACS system incorporating Wireless

OAKVILLE, ON, Aug. 23 /CNW/ - MDX Corporation has received FDA clearance
for the marketing and sales of the Insight(TM) PACS/RIS System in the United
States. This is a major step for the company - the Insight solution is now
available for hospitals and clinics in the world's leading healthcare market.
The clearance is also a significant endorsement of the Insight system and its
support of wireless and remote devices.
Insight(TM) is the first PACS/RIS system cleared to market by the US FDA
that includes wireless or mobile handheld devices that function as full-
featured clinical workstations - with access to all image data at full-
resolution and access to all necessary tools, even for volume reconstructions
and 3D analysis. 24/7 access to all necessary patient information at all
locations is expected to transform workflows within healthcare enterprises and
to improve patient care.
Zoran Popovic, President and CEO of MDX, explains, "For us this is a
significant step towards realizing our vision of pervasive healthcare IT
systems. We can now give clinicians a liberating choice - unfettered access to
the systems they rely on daily. No other PACS/RIS systems on the market can
offer such functionality."
The clearance granted by the FDA covers the complete Insight system,
including the innovative architecture of the system, the deployment of
wireless and mobile handheld devices as clinical review workstations (PDAs and
SmartPhones), the distribution technology (streaming), a number of Clinical
Application Modules, and the VPS integration engine, which communicates with
existing digital PACS archives. Via the VPS (Virtualized PACS Services), sites
that already have digital PACS systems can employ the Insight(TM) system to
easily distribute access to the existing data throughout the enterprise.

About MDX Corporation

MDX, a division of DXStorm.com Inc. (TSX:DXX), specializes in Medical
Imaging solutions. MDX currently has two main product lines: Insight(TM)
PACS/RIS and the Galileo(TM) Fusion Suite. Insight and Galileo(TM) have both
enjoyed considerable success in Europe and Asia and are now being introduced
to the North American market.

Website: http://www.mdxcorp.com/

The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.